annual EBITDA:
-$290.98M-$330.87M(-829.45%)Summary
- As of today (September 18, 2025), AMLX annual EBITDA is -$290.98 million, with the most recent change of -$330.87 million (-829.45%) on December 31, 2024.
- During the last 3 years, AMLX annual EBITDA has fallen by -$208.34 million (-252.12%).
- AMLX annual EBITDA is now -829.45% below its all-time high of $39.89 million, reached on December 31, 2023.
Performance
AMLX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$42.72M-$5.07M(-13.46%)Summary
- As of today (September 18, 2025), AMLX quarterly EBITDA is -$42.72 million, with the most recent change of -$5.07 million (-13.46%) on June 1, 2025.
- Over the past year, AMLX quarterly EBITDA has increased by +$10.51 million (+19.75%).
- AMLX quarterly EBITDA is now -308.55% below its all-time high of $20.48 million, reached on June 30, 2023.
Performance
AMLX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$196.30M+$10.51M(+5.08%)Summary
- As of today (September 18, 2025), AMLX TTM EBITDA is -$196.30 million, with the most recent change of +$10.51 million (+5.08%) on June 1, 2025.
- Over the past year, AMLX TTM EBITDA has dropped by -$42.51 million (-27.64%).
- AMLX TTM EBITDA is now -592.10% below its all-time high of $39.89 million, reached on December 31, 2023.
Performance
AMLX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMLX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -829.5% | +19.8% | -27.6% |
| 3 y3 years | -252.1% | +21.1% | -50.7% |
| 5 y5 years | -2239.0% | -397.3% | -2185.2% |
AMLX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -829.5% | at low | -308.6% | +64.9% | -592.1% | +32.5% |
| 5 y | 5-year | -829.5% | at low | -308.6% | +64.9% | -592.1% | +32.5% |
| alltime | all time | -829.5% | at low | -308.6% | +64.9% | -592.1% | +32.5% |
AMLX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.72M(+13.5%) | -$196.30M(-5.1%) |
| Mar 2025 | - | -$37.65M(-7.0%) | -$206.81M(-28.9%) |
| Dec 2024 | -$290.98M(-829.4%) | -$40.49M(-46.3%) | -$290.98M(+17.2%) |
| Sep 2024 | - | -$75.44M(+41.7%) | -$248.25M(+61.4%) |
| Jun 2024 | - | -$53.23M(-56.3%) | -$153.78M(+92.0%) |
| Mar 2024 | - | -$121.81M(-5550.3%) | -$80.08M(-300.7%) |
| Dec 2023 | $39.89M | $2.23M(-88.3%) | $39.89M(-690.4%) |
| Sep 2023 | - | $19.02M(-7.1%) | -$6.76M(-91.6%) |
| Jun 2023 | - | $20.48M(-1207.7%) | -$80.29M(-48.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$1.85M(-95.8%) | -$154.92M(-22.9%) |
| Dec 2022 | -$200.85M(+143.1%) | -$44.41M(-18.5%) | -$200.85M(+8.7%) |
| Sep 2022 | - | -$54.52M(+0.7%) | -$184.74M(+41.9%) |
| Jun 2022 | - | -$54.15M(+13.3%) | -$130.22M(+37.6%) |
| Mar 2022 | - | -$47.78M(+68.9%) | -$94.65M(+58.5%) |
| Dec 2021 | -$82.64M(+106.6%) | -$28.29M(+52.3%) | -$59.73M(+49.2%) |
| Jun 2021 | - | -$18.58M(+44.5%) | -$40.02M(+86.6%) |
| Mar 2021 | - | -$12.86M(+49.7%) | -$21.45M(+149.7%) |
| Dec 2020 | -$39.99M(+221.5%) | -$8.59M | -$8.59M |
| Dec 2019 | -$12.44M | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AMLX is -$290.98M
What is the all time high annual EBITDA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual EBITDA is $39.89M
What is Amylyx Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AMLX annual EBITDA has changed by -$330.87M (-829.45%)
What is Amylyx Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AMLX is -$42.72M
What is the all time high quarterly EBITDA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly EBITDA is $20.48M
What is Amylyx Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AMLX quarterly EBITDA has changed by +$10.51M (+19.75%)
What is Amylyx Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AMLX is -$196.30M
What is the all time high TTM EBITDA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM EBITDA is $39.89M
What is Amylyx Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AMLX TTM EBITDA has changed by -$42.51M (-27.64%)